Daré Bioscience Investor Relations Material
Latest events
Q3 2023
Daré Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Daré Bioscience Inc
Access all reports
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing and marketing products for women's health. The firm focuses on women's reproductive health management which includes contraception and treatment of endometriosis and infertility. Daré Bioscience is developing VASCAZEN as a nonhormonal oral contraceptive that is intended to have no estrogen or progestin side effects such as weight gain and fluid retention as well as its potential effect by regulatory authorities to make it available more quickly than fully approved new drugs.
Key slides for Daré Bioscience Inc
Corporate Presentation
Daré Bioscience Inc
Corporate Presentation
Daré Bioscience Inc
Latest articles
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
John Elkann: Leading Stellantis, Ferrari, and Exor to New Heights
As the Chairman of Stellantis and Ferrari and CEO of Exor, John Elkann is arguably the most influential person in the global automotive sector.
26 Mar 2024
Ticker symbol
Country
🇺🇸 United States